Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina|January 1, 1995
[Acute phase factors in blood of patients with subarachnoid hemorrhage in its earliest phase]W Kawiak, J Iłzecka, H Bartosik-PsujekAnnales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina|January 1, 1996
Pathogenesis and clinical aspects of malignant hyperpyrexia (MH)M Psujek, H Bartosik-Psujek, J WojczalNeurologia I Neurochirurgia Polska|March 26, 1998
[Dialysis therapy and central nervous system disturbances]H Bartosik-Psujek, K Mitosek-Szewczyk, J WojczalAnnales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina|January 1, 1996
Uraemic autonomic neuropathyH Bartosik-Psujek, M Psujek, K Mitosek-SzewczykActa Neurologica Scandinavica|July 6, 2010
Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantroneH Bartosik-Psujek, M Psujek, J Jaworski, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2008
Paraoxonase 1 activity in different types of multiple sclerosisA Jamroz-Wisniewska, J Beltowski, Z Stelmasiak, et al.Clinical Nephrology|June 9, 2004
Vascular abnormalities in patients with autosomal dominant polycystic kidney disease--the influence on arteriovenous fistula creationW Weyde, M Krajewska, J Penar, et al.Acta Neurologica Scandinavica|February 24, 2010
Impact of cladribine on soluble adhesion molecules in multiple sclerosisKrystyna Mitosek-Szewczyk, Z Stelmasiak, H Bartosik-Psujek, et al.Acta Neurologica Scandinavica|August 14, 2012
Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapyA Jamroz-Wisniewska, J Beltowski, Z Stelmasiak, et al.The International Journal of Neuroscience|September 28, 2016
Processes of plasma protein N-homocysteinylation in multiple sclerosisA Jamroz-Wiśniewska, J Bełtowski, H Bartosik-Psujek, et al.Pageof 3